Stock A256840 BNC KOREA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company BNC Korea Co., Ltd.

Equities

A256840

KR7256840000

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
6,130 KRW -1.45% Intraday chart for BNC Korea Co., Ltd. -1.13% +65.68%
03-25 Hankook Korus Pharm Co., Ltd. announced that it has received KRW 2 billion in funding from BNC Korea Co., Ltd. CI
2023 NovMetaPharma Co., Ltd. announced that it has received KRW 6.99999258 billion in funding from BNC Korea Co., Ltd. CI

Business Summary

BNC Korea Co. Ltd, formerly NH Special Purpose Acquisition 11 Co., Ltd., is a Korea-based company principally engaged in the manufacture and sale of biopharmaceuticals. The Company's main products include hyaluronic acid (HA) fillers, collagen wound dressings, antiadhesion materials and collagen tissue supplements, and others. In addition, the Company produces and sells cosmetics, medicines and medical devices, among others.

Number of employees: 174

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medical Devices, Pharmaceuticals, and Health Supplements Product
62.8 %
- - 50,828 62.8 % -
Medical Devices, Pharmaceuticals, and Health Supplements Merchandise
36.8 %
- - 29,806 36.8 % -
Other
0.4 %
- - 363 0.4 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
51.3 %
32,583 77.0 % 41,552 51.3 % +27.53%
Overseas Others
46.2 %
8,710 20.6 % 37,437 46.2 % +329.84%
Russia
2.5 %
1,011 2.4 % 2,008 2.5 % +98.72%

Managers

Managers TitleAgeSince
Wan-Kyu Choi CEO
 Chief Executive Officer 66 19-11-18
Seong-Myeong Hwang SAM
 Sales & Marketing 54 -
Jae-Myeong Yang AUD
 Comptroller/Controller/Auditor 73 19-10-10

Members of the board

Members of the board TitleAgeSince
Wan-Kyu Choi CEO
 Chief Executive Officer 66 19-11-18
Man-Seok Jo BRD
 Director/Board Member 59 19-10-10
Seong-Won Hong BRD
 Director/Board Member 73 19-10-10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 67,912,443 52,966,894 ( 77.99 %) 1,548,291 ( 2.280 %) 77.99 %

Shareholders

NameEquities%Valuation
Wan-Kyu Choi
20.04 %
13,608,918 20.04 % 75 M ₩
BNC KOREA CO., LTD.
2.280 %
1,548,291 2.280 % 9 M ₩
Dimensional Fund Advisors Ltd.
0.0290 %
19,689 0.0290 % 108 518 ₩
DFA Australia Ltd.
0.0245 %
16,638 0.0245 % 91 702 ₩

Holdings

NameEquities%Valuation
BNC KOREA CO., LTD.
2.28%
 1,548,291 2.28% 8,533,576 $

Company contact information

BNC Korea Co., Ltd.

62 Seongseogongdan-ro 11-gil Dalseo-gu

42713, Daegu

+

http://www.bnckorea.co.kr
address BNC Korea Co., Ltd.(A256840)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
BNC KOREA CO., LTD. Stock BNC Korea Co., Ltd.
+65.68% 300M
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.45% 40.51B
BIOGEN INC. Stock Biogen Inc.
-15.94% 31.67B
UCB Stock UCB
+52.66% 24.62B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-14.50% 15.65B
INCYTE CORPORATION Stock Incyte Corporation
-14.38% 12.07B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.97B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.87% 8.81B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-4.33% 8.5B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A256840 Stock
  4. Company BNC Korea Co., Ltd.